Articles of association

§ 1

The company’s name is Pronova BioPharma ASA. The company is a public limited liability company.

§ 2

The company’s registered office is in Bærum municipality.

§ 3

The company’s objective is, by itself, or through participation in or together with, other companies to develop, produce and sell pharmaceutical products, as well as other related activities.

§ 4

The share capital of the company is NOK 6,016,650 distributed on 300,832,508 shares, each with a nominal value of NOK 0.02. The company’s shares shall be registered in the Norwegian Central Securities Depository.

§ 5

The company’s board of directors shall consist of 3 — 9 members in accordance with resolution made by the general meeting.

§ 6

The signature of the company is held by two board members jointly. The board of directors may grant power of attorney.

§ 7

The company shall have a nomination committee. The nomination committee shall consist of 3 members who shall be shareholders or representatives for the shareholders. The members of the nomination committee, including its chairman, shall be appointed by the general meeting for a duration of two years. The nomination committee presents its recommendation for members to the board of directors elected by the shareholders. Remuneration to the members of the nomination committee shall be adopted by the general meeting.

§ 8

The ordinary general meeting shall handle the following matters:

1. Adoption of the annual accounts and annual report, including distribution of dividend.

2. Determine the remuneration to the board of directors and approve the auditor’s fee.

3. Other matters which, in accordance with law or the articles of association is the responsibility of the general meeting.